These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15751005)

  • 1. Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye.
    Fujii K; Kondo T; Yokoo H; Yamada T; Iwatsuki K; Hirohashi S
    Proteomics; 2005 Apr; 5(5):1411-22. PubMed ID: 15751005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues.
    Sun W; Xing B; Sun Y; Du X; Lu M; Hao C; Lu Z; Mi W; Wu S; Wei H; Gao X; Zhu Y; Jiang Y; Qian X; He F
    Mol Cell Proteomics; 2007 Oct; 6(10):1798-808. PubMed ID: 17627933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Database of two-dimensional polyacrylamide gel electrophoresis of proteins labeled with CyDye DIGE Fluor saturation dye.
    Fujii K; Kondo T; Yokoo H; Okano T; Yamada M; Yamada T; Iwatsuki K; Hirohashi S
    Proteomics; 2006 Mar; 6(5):1640-53. PubMed ID: 16429455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins.
    Kim J; Kim SH; Lee SU; Ha GH; Kang DG; Ha NY; Ahn JS; Cho HY; Kang SJ; Lee YJ; Hong SC; Ha WS; Bae JM; Lee CW; Kim JW
    Electrophoresis; 2002 Dec; 23(24):4142-56. PubMed ID: 12481271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry.
    Liang CR; Leow CK; Neo JC; Tan GS; Lo SL; Lim JW; Seow TK; Lai PB; Chung MC
    Proteomics; 2005 May; 5(8):2258-71. PubMed ID: 15852300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry.
    Seow TK; Ong SE; Liang RC; Ren EC; Chan L; Ou K; Chung MC
    Electrophoresis; 2000 May; 21(9):1787-813. PubMed ID: 10870966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C.
    Blanc JF; Lalanne C; Plomion C; Schmitter JM; Bathany K; Gion JM; Bioulac-Sage P; Balabaud C; Bonneu M; Rosenbaum J
    Proteomics; 2005 Sep; 5(14):3778-89. PubMed ID: 16097030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma tissues].
    Song HY; Liu YK; Cui JF; Zhang LJ; Dai Z; Feng JT; Feng JX; Shen HL; Yang PY
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):331-4. PubMed ID: 15918964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification by differential tissue proteome analysis of talin-1 as a novel molecular marker of progression of hepatocellular carcinoma.
    Kanamori H; Kawakami T; Effendi K; Yamazaki K; Mori T; Ebinuma H; Masugi Y; Du W; Nagasaka K; Ogiwara A; Kyono Y; Tanabe M; Saito H; Hibi T; Sakamoto M
    Oncology; 2011; 80(5-6):406-15. PubMed ID: 21846996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential proteomic analysis of hepatocellular carcinoma.
    Corona G; De Lorenzo E; Elia C; Simula MP; Avellini C; Baccarani U; Lupo F; Tiribelli C; Colombatti A; Toffoli G
    Int J Oncol; 2010 Jan; 36(1):93-9. PubMed ID: 19956837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues.
    Song HY; Liu YK; Feng JT; Cui JF; Dai Z; Zhang LJ; Feng JX; Shen HL; Tang ZY
    J Cancer Res Clin Oncol; 2006 Feb; 132(2):92-8. PubMed ID: 16261346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome analysis of a human heptocellular carcinoma cell line, HCC-M: an update.
    Ou K; Seow TK; Liang RC; Ong SE; Chung MC
    Electrophoresis; 2001 Aug; 22(13):2804-11. PubMed ID: 11545412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.
    Yi X; Luk JM; Lee NP; Peng J; Leng X; Guan XY; Lau GK; Beretta L; Fan ST
    Mol Cell Proteomics; 2008 Feb; 7(2):315-25. PubMed ID: 17934217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers.
    Li C; Tan YX; Zhou H; Ding SJ; Li SJ; Ma DJ; Man XB; Hong Y; Zhang L; Li L; Xia QC; Wu JR; Wang HY; Zeng R
    Proteomics; 2005 Mar; 5(4):1125-39. PubMed ID: 15759316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic identification of the macrophage-capping protein as a protein contributing to the malignant features of hepatocellular carcinoma.
    Kimura K; Ojima H; Kubota D; Sakumoto M; Nakamura Y; Tomonaga T; Kosuge T; Kondo T
    J Proteomics; 2013 Jan; 78():362-73. PubMed ID: 23085225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myofibroblasts are important contributors to human hepatocellular carcinoma: evidence for tumor promotion by proteome profiling.
    Slany A; Haudek-Prinz V; Zwickl H; Stättner S; Grasl-Kraupp B; Gerner C
    Electrophoresis; 2013 Dec; 34(24):3315-25. PubMed ID: 24115093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
    Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
    Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma.
    Chaerkady R; Harsha HC; Nalli A; Gucek M; Vivekanandan P; Akhtar J; Cole RN; Simmers J; Schulick RD; Singh S; Torbenson M; Pandey A; Thuluvath PJ
    J Proteome Res; 2008 Oct; 7(10):4289-98. PubMed ID: 18715028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma.
    Park KS; Kim H; Kim NG; Cho SY; Choi KH; Seong JK; Paik YK
    Hepatology; 2002 Jun; 35(6):1459-66. PubMed ID: 12029631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.